6 
Dr. Robbins reported that planning is moving ahead for a joint NIOSH-EPA 
project to assess the adequacy of currently used "control technology." A CDC- 
NIOSH recombinant DNA surveillance group met for the first time on October 23, 
and will make recommendations concerning: (1) medical surveillance of potentially 
exposed workers; (2) central collection and analyses of medical surveillance 
data for epidemiology; and (3) establishing an emergency response team. 
Chairman's Summation 
Dr. Omenn said that industry and government have behaved responsibly and 
have made hasty legislation unnecessary. He expects to leave government shortly. 
If so, the Director, NIH, will appoint a new Subcommittee chairman. The Sub- 
committee executive secretary will contact members concerning the next meeting. 
Dr. Omenn extended his best wishes to the Subcommittee members, and thanked them 
for their constructive participation in these fruitful meetings. 
Bernard Talbot, M.D., Ph.D. 
Subcommittee Executive Secretary 
January 12, 1981 
[530] 
